Fig. 1
From: Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
The flow chart of patients eligibility of the clinical trial
Fig. 1 | BMC Gastroenterology
From: Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
The flow chart of patients eligibility of the clinical trial
